Skip to main content

Table 2 Demographics of patients prior to CRRT

From: Evaluation of circuit lifetime in continuous renal replacement therapy using two types of polysulfone membranes

 

SHG group

AEF group

p

Number

8

9

Session

10

14

Age (years)

56 [38–76]

63 [41–65]

0.962

Gender (male/female)

3/5

6/3

0.347

Etiology of AKI

 Sepsis

4

5

 

 Severe acute pancreatitis

1

1

 

 Other

3

3

1.000

APACHE II score

24 [22–27]

23 [16–25]

0.629

SOFA score

10 [9–12]

9 [7–10]

0.525

DIC score

5 [5–7]

5 [5–7]

0.763

KDIGO stage

1 [1–3]

1 [1–3]

0.956

Laboratory data

 TP (g/dL)

5.5 [5.1–5.5]

5.5 [5.2–5.5]

0.730

 Hematocrit (%)

29.8 [22.5–34.2]

30.9 [24.3–35.7]

1.000

 Platelet (× 104/μL)

32.5 [23.0–48.3]

95.0 [40.0–245.0]

0.176

 APTT (s)

45.8 [41.0–57.8]

45.5 [37.9–65.1]

1.000

 ACT (s)

272 [256–284]

241 [208–291]

0.334

  1. CRRT continuous renal replacement therapy, APACHE acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, DIC disseminated intravascular coagulation, KDIGO Kidney Disease Improving Global Outcomes, TP total protein, APTT activated partial thromboplastin time, ACT activated coagulation time